Mediclinic completes R5bn rights issue
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Emerging Markets

Mediclinic completes R5bn rights issue

Mediclinic’s R5bn ($568m) rights issue was 99.7% subscribed, the company said on Monday. The South African private healthcare company, which is listed on the Johannesburg Stock Exchange, will use proceeds from the deal to support a R28bn loan refinancing.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article